Zobrazeno 1 - 10
of 299
pro vyhledávání: '"E. N. Aleksandrova"'
Autor:
L. A. Kolomiets, M. N. Stakheeva, O. N. Churuksaeva, A. B. Villert, A. L. Chernyshova, V. G. Sisakyan, I. Yu. Lots, N. M. Chernorubashkina, V. N. Zhurman, A. A. Grechkina, E. N. Aleksandrova, N. E. Musaeva, O. V. Diduk, N. A. Bulygina, D. A. Pyatina, I. L. Obraz, A. V. Krechetova, M. A. Danilova, M. A. Khodzhakhova, A. A. Malsteva, N. A. Ermak
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 2, Pp 109-118 (2023)
Background. Endometrial cancer (EC) is one of the most significant oncogynecological problems. The main mortality cause in this disease, as in the case of other malignant neoplasms, is the tumor progression. The presence of mutations associated with
Externí odkaz:
https://doaj.org/article/ff8dd3121d334a85a54b0fbe8ef22913
Autor:
L. A. Kolomiets, S. E. Krasil'nikov, N. E. Musaeva, D. Yu. Yukal'chuk, O. N. Churuksaeva, L. D. Zhuykova, N. M. Chernorubashkina, L. A. Tashireva, M. A.-K. Hodzhahova, O. V. Zharkova, E. N. Aleksandrova, V. N. Zhurman, A. A. Grechkina, V. G. Sisakyan, D. O. Pavlova, E. M. Pshevlocky, A. A. Gofman, A. V. Tarhov, A. V. Tereshchenko, N. A. Byuksel', A. A. Filippov, D. N. Kushlinsky
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 177-183 (2023)
Externí odkaz:
https://doaj.org/article/e02211346d0b418891d0662e6e99a4bb
Publikováno v:
Туберкулез и болезни лёгких, Vol 99, Iss 12, Pp 33-37 (2022)
Subjects and Methods. Incidence and prevalence of tuberculosis among children and adolescents in Saratov Region were retrospectively analyzed for 2015-2019.Results. The incidence of tuberculosis in children reflects general trends in the epidemic sit
Externí odkaz:
https://doaj.org/article/5449d03ddbf74fb4abbda6216e1e4d5d
Publikováno v:
Терапевтический архив, Vol 93, Iss 2, Pp 228-235 (2021)
Inflammatory bowel disease IBD (Crohns disease CD, ulcerative colitis UC) immune-mediated diseases of the digestive tract of unknown etiology. The basis of the pathogenesis of IBD is a violation of the protective mechanisms of the intestinal barrier
Externí odkaz:
https://doaj.org/article/7158cd69ea6a465790c2f5db9d36a84e
Autor:
A. A. Mesnyankina, S. K. Solovyev, E. A. Aseeva, A. P. Aleksankin, E. N. Aleksandrova, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 13, Iss 1, Pp 35-43 (2019)
Objective: to evaluate the effect of different biological agents (BAs), including rituximab (RTM) and belimumab (BLM) combination therapy, on B-lymphocyte subpopulations during a follow-up of patients with systemic lupus erythematosus (SLE).Patients
Externí odkaz:
https://doaj.org/article/5fddb8487ffd492c9c81448d174933e5
Autor:
T. A. Panafidina, M. A. Sokhova, T. V. Popkova, D. S. Novikova, E. N. Aleksandrova, Yu. O. Korsakova, A. V. Volkov
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 4, Pp 376-381 (2017)
Objective: to determine the level of the N-terminal fragment of brain natriuretic peptide progenitor (NT-proBNP) in patients with systemic lupus erythematous (SLE) prior to immunosuppressive therapy and its possible association with inflammatory mark
Externí odkaz:
https://doaj.org/article/5949634d8b424040a77275e020e0fae2
Autor:
M. A. Borisova, G. V. Lukina, Ya. A. Sigidin, E. L. Luchikhina, D. E. Karateev, A. A. Novikov, E. N. Aleksandrova, M. V. Cherkasova, E. S. Aronova, S. L. Glukhova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 4, Pp 368-375 (2017)
Objective: to estimate changes in the cytokine profile in patients receiving abatacept (ABC).Subjects and methods. The investigation enrolled 44 patients with rheumatoid arthritis (RA) who had been unsuccessfully treated with disease-modifying antirh
Externí odkaz:
https://doaj.org/article/eea8a63e1d194d8db1654ec7fabbc6bb
Autor:
A. A. Mesnyankina, S. K. Solovyev, E. N. Aleksandrova, A. P. Aleksankin, E. V. Suponitskaya, A. V. Elonakov, E. A. Aseeva, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 3, Pp 252-260 (2017)
Objective: to study the baseline level and time course of changes in peripheral blood B cell subpopulations in patients with systemic lupus erythematosus (SLE) versus the clinical manifestations of the disease during therapy with rituximab (RTM) and
Externí odkaz:
https://doaj.org/article/67d32a1d995548d8a2dba5cd6cb8caf1
Autor:
M. Yu. Krylov, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, E. Yu. Samarkina, O. V. Desinova, O. B. Ovsyannikova, E. N. Aleksandrova, A. A. Novikov, I. A. Guseva
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 1, Pp 37-40 (2017)
The FAS antigen (Apo-1/CD95) is a key molecule of apoptosis in most cell types, including activated immune cells and fibroblasts. The FAS gene promoter region contains a single-nucleotide polymorphism (-670A/G) associated with a substitution of the n
Externí odkaz:
https://doaj.org/article/8b74491bd30c4e2aa5e61a38fc9bf40c
Autor:
E. N. Aleksandrova, A. A. Novikov
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 1, Pp 96-103 (2017)
Ankylosing spondylitis (AS) is a chronic inflammatory disease from a group of spondyloarthritis (SpA), which is characterized by lesions of the sacroiliac joints and spine with the common involvement of entheses and peripheral joints in the pathologi
Externí odkaz:
https://doaj.org/article/937087b27a444cd08958d91bd71b9185